Chondrocalcinosis: the crystals are real, but are they the cause?

Calcium crystals show up in a lot of joints, and most of them never hurt. That is worth knowing before you blame them for everything.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

What chondrocalcinosis is

Chondrocalcinosis means calcium crystals in cartilage. The crystals are calcium pyrophosphate, so the condition is also called calcium pyrophosphate deposition disease, or CPPD. When the crystals set off a sudden attack of joint inflammation, it is called pseudogout because it looks so much like gout, with a hot, red, swollen, very painful joint, most often the knee or wrist. CPPD can also cause a slower, grinding arthritis that behaves like osteoarthritis, and a rarer form that mimics rheumatoid arthritis.

Diagnosis rests on finding the crystals in joint fluid or seeing the calcification on X-ray or ultrasound. Acute attacks are treated with anti-inflammatory medication, steroid injections or colchicine, and they settle. There is no treatment that dissolves the crystals.

The important fact for anyone with this diagnosis is that calcification on imaging is very common in older adults and is, on its own, painless. Reviews put the rate of chondrocalcinosis in people over 60 at somewhere between 4 and 10 percent, and higher with age, and most of them have no symptoms. So a scan that shows crystals tells you crystals are present. It does not automatically tell you they are the reason you hurt.

The neuroplastic contribution

Neuroplastic symptoms are real symptoms produced by learned pathways in the brain and nervous system rather than by ongoing damage in the body. Pain is an alarm the brain generates to protect you. After a genuinely painful pseudogout attack, that alarm can stay switched on, or become more sensitive, even when the inflammation has resolved. The pain is real. It is not imaginary and not 'all in your head'. And because the brain can change, a sensitized alarm can be turned down again.

The ATNS Index of Neuroplastic Symptoms does not say chondrocalcinosis is neuroplastic. Its position is that the condition is not linked to neuroplastic symptoms, but that if this structural finding does not fully explain your symptoms, or if your response to treatment is atypical or not enough, then evaluating for neuroplastic symptoms is appropriate and likely to be helpful. That is a precise claim, and it maps onto the three situations people with a CPPD diagnosis most often find themselves in:

• The scan shows crystals in a joint that is not where most of the pain is, or in both knees when only one hurts.
• The acute attacks respond to treatment, but a constant background ache never leaves.
• Pain has spread to a wider area, or several joints feel sensitive, and the imaging cannot account for it.

In each case the crystals are real and the pain is real, but the link between them is weaker than it first appears. That gap is where central sensitization often lives. The same pattern is well described in osteoarthritis, which CPPD so often resembles.

What the research shows

We should be honest: no study has tested neuroplastic symptoms in chondrocalcinosis specifically. What the research does establish, again and again, is a mismatch between crystals and symptoms.

• A 2024 narrative review of chondrocalcinosis describes radiographic chondrocalcinosis as asymptomatic in itself. Symptoms come from the clinical forms: acute attacks and an osteoarthritis-like arthritis.
• A 2025 review of CPPD disease describes three clinical forms, asymptomatic, acute and chronic, and reports that the asymptomatic form is the most common.
• The Framingham Study, a large population study of older adults, found chondrocalcinosis was common and was linked to knee osteoarthritis after allowing for age, but it accounted for only a small share of the osteoarthritis seen.
• A study of people having a knee replacement for end-stage osteoarthritis found no difference in pain, function or complications after surgery between those who had chondrocalcinosis and those who did not.

Put together, these findings show that the presence of crystals does a poor job of predicting who hurts and how much. None of these studies measured the nervous system directly, so the idea that sensitization explains the gap is an inference, not a finding. That is why the ATNS index frames the question as 'evaluate' rather than 'assume'.

Signs the brain may be part of the picture

• Your pain is out of proportion to what the X-ray, ultrasound or joint fluid shows.
• Crystals are present in joints that do not hurt, or on the side that hurts less.
• Attacks settle with treatment but a constant ache persists between them.
• Pain flares with stress, poor sleep or worry more than with activity.

A solution that addresses it

Pain and symptom reprocessing is an approach built for the gap between structure and symptoms. It combines education about neuroplastic pain, somatic tracking (attending to the sensation with curiosity rather than dread), reducing fear and the sense of threat, a graded return to movement, emotional awareness and expression, and acceptance and commitment skills. Trained clinicians deliver it, and digital programs now make it more accessible. It works alongside your rheumatologist's care for acute attacks, not instead of it.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose pain has a neuroplastic component. If your pain has outlasted your pseudogout attacks, you can join the waitlist.

What to do next

1. Get the diagnosis confirmed. A hot, swollen joint should always be assessed promptly, because infection, gout and CPPD can look identical and infection is an emergency. Joint fluid analysis settles it.
2. Treat the attacks. Follow your clinician's plan for acute flares and for any underlying condition linked to CPPD, such as thyroid or parathyroid problems.
3. Ask whether the crystals explain all of it. If a background ache or widespread pain persists between attacks, raise the question. The ATNS index says that is the moment to evaluate for neuroplastic symptoms.
4. Start learning and moving. Understand that hurt is not harm in a joint that has calmed down, and rebuild activity gradually.

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.